Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLC η1 Inhibitors

Chemical inhibitors of PLC η1 can exert their inhibitory action through various mechanisms that interfere with the protein's function at the cellular and biochemical levels. U73122, for instance, targets PLC η1 directly by disrupting its catalytic activity, preventing the hydrolysis of phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol trisphosphate, which are essential secondary messengers for transmitting signals within the cell. Similarly, edelfosine employs a mechanism of action that involves mimicking lysophosphatidylcholine, a natural substrate of PLC, thereby inhibiting the enzymatic activity of PLC η1 and obstructing the downstream signaling pathways. D609, another inhibitor, impedes the action of PLC η1 by inhibiting the conversion of phosphatidylcholine to diacylglycerol, a critical step in the PLC η1 mediated signaling process.

Furthermore, ET-18-OCH3 operates by interfering with PLC η1's substrate recognition, halting the generation of secondary messengers crucial to PLC η1's signaling functions. Neomycin binds to phosphoinositides, thus preventing PLC η1 from interacting with its substrate and stopping the signal transduction process mediated by PLC. Ro 31-8220 inhibits PLC η1 indirectly by preventing the activation of protein kinase C, an enzyme necessary for the activation of PLC η1 in certain signaling contexts. U73343, although typically less active, has been reported to inhibit PLC η1 activity, possibly through non-specific interactions with the enzyme or its associated membrane structures. CI-1040, while primarily targeting MAP kinase, disrupts downstream pathways that are essential for the activation of PLC η1. Manumycin A blocks the farnesylation of proteins that are part of the PLC η1 regulatory mechanism, thereby inhibiting its activity. Halopemide, a dopamine receptor antagonist, impedes PLC η1 by inhibiting the dopamine receptor-mediated activation of the enzyme. Lyso-PC and miltefosine inhibit PLC η1 by integrating into cellular membranes and altering their composition, which is critical for the proper function and localization of PLC enzymes within the lipid bilayer.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Edelfosine

70641-51-9sc-507459
5 mg
$216.00
(0)

As a synthetic alkyl-lysophospholipid, edelfosine can inhibit PLC η1 by mimicking lysophosphatidylcholine, thereby disrupting the enzymatic activity of PLC η1 and its downstream signaling cascade.

D609

83373-60-8sc-201403
sc-201403A
5 mg
25 mg
$185.00
$564.00
7
(1)

D609 is a tricyclodecan-9-yl-xanthogenate that inhibits phosphatidylcholine-specific PLC, thus it would also inhibit PLC η1 by preventing the conversion of phosphatidylcholine to diacylglycerol, a crucial step in PLC η1 signaling pathway.

Neomycin sulfate

1405-10-3sc-3573
sc-3573A
1 g
5 g
$26.00
$34.00
20
(5)

Neomycin, an aminoglycoside antibiotic, binds to phosphoinositides and can inhibit PLC η1 by preventing its interaction with its substrate, effectively stopping the PLC-mediated signaling.

Ro 31-8220

138489-18-6sc-200619
sc-200619A
1 mg
5 mg
$90.00
$240.00
17
(1)

Ro 31-8220 functions as a protein kinase C inhibitor and can inhibit PLC η1 by preventing the activation of protein kinase C, which is necessary for full activation of PLC η1 in certain signaling pathways.

U-73343

142878-12-4sc-201422
sc-201422A
5 mg
25 mg
$91.00
$343.00
17
(1)

U73343, the inactive analog of U73122, acts as a control compound but has been reported to inhibit PLC η1 activity in certain contexts, likely through non-specific interactions with the enzyme or its membrane environment.

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$215.00
$622.00
5
(1)

Manumycin A inhibits farnesyltransferase and can indirectly inhibit PLC η1 by blocking the farnesylation of proteins that interact with or regulate PLC η1 activity.

Miltefosine

58066-85-6sc-203135
50 mg
$79.00
8
(1)

Miltefosine, an alkylphosphocholine drug, can inhibit PLC η1 by altering the membrane lipid composition, which is critical for the proper function and localization of PLC enzymes.